Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isaac Y Kim

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Urologic Oncology|November 18, 2018
Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuriaYanjie Xu, Ye-Hwan Kim, Pildu Jeong, et al.
Urologic Oncology|July 9, 2019
Accuracy of clinical nodal staging and factors associated with receipt of lymph node dissection at the time of surgery for nonmetastatic renal cell carcinomaKushan D Radadia, Zorimar Rivera-Núñez, Sinae Kim, et al.
Cancer|September 26, 2018
Comparative effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancerThomas L Jang, Neal Patel, Izak Faiena, et al.
Clinical Genitourinary Cancer|May 12, 2020
Factors Associated With Receipt of Partial Nephrectomy or Minimally Invasive Surgery for Patients With Clinical T1a and T1b Renal Masses: Implications for Regionalization of CareJoshua Sterling, Zorimar Rivera-Núñez, Hiren V Patel, et al.
Journal of Clinical Urology|March 12, 2019
Effect of alvimopan on gastrointestinal recovery and length of hospital stay after retroperitoneal lymph node dissection for testicular cancerKushan D Radadia, Nicholas J Farber, Alexandra L Tabakin, et al.
Urologic Oncology|November 18, 2018
Trends and outcomes of lymphadenectomy for nonmetastatic renal cell carcinoma: A propensity score-weighted analysis of the National Cancer DatabaseNicholas J Farber, Zorimar Rivera-Núñez, Sinae Kim, et al.
Clinical Genitourinary Cancer|December 11, 2019
Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014Alexandra L Tabakin, Brian M Shinder, Sinae Kim, et al.
BMC Complementary Medicine and Therapies|July 4, 2025
Project HERO: a randomized trial of Tai Chi qigong versus intensity-matched exercise and usual care for fatigue in older male cancer survivorsAnita Y Kinney, Jinghua An, Yong Lin, et al.
Oncology Letters|January 4, 2020
A novel tumor suppressing gene, <i>ARHGAP9</i>, is an independent prognostic biomarker for bladder cancerXuan-Mei Piao, Pildu Jeong, Chunri Yan, et al.
Cancer Gene Therapy|June 22, 2019
Phase I neoadjuvant study of intravesical recombinant fowlpox-GM-CSF (rF-GM-CSF) or fowlpox-TRICOM (rF-TRICOM) in patients with bladder carcinomaDaniella E Portal, Robert E Weiss, Malgorzata Wojtowicz, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Urologic Oncology|November 18, 2018
Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuriaYanjie Xu, Ye-Hwan Kim, Pildu Jeong, et al.
Urologic Oncology|July 9, 2019
Accuracy of clinical nodal staging and factors associated with receipt of lymph node dissection at the time of surgery for nonmetastatic renal cell carcinomaKushan D Radadia, Zorimar Rivera-Núñez, Sinae Kim, et al.
Cancer|September 26, 2018
Comparative effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancerThomas L Jang, Neal Patel, Izak Faiena, et al.
Clinical Genitourinary Cancer|May 12, 2020
Factors Associated With Receipt of Partial Nephrectomy or Minimally Invasive Surgery for Patients With Clinical T1a and T1b Renal Masses: Implications for Regionalization of CareJoshua Sterling, Zorimar Rivera-Núñez, Hiren V Patel, et al.
Journal of Clinical Urology|March 12, 2019
Effect of alvimopan on gastrointestinal recovery and length of hospital stay after retroperitoneal lymph node dissection for testicular cancerKushan D Radadia, Nicholas J Farber, Alexandra L Tabakin, et al.
Urologic Oncology|November 18, 2018
Trends and outcomes of lymphadenectomy for nonmetastatic renal cell carcinoma: A propensity score-weighted analysis of the National Cancer DatabaseNicholas J Farber, Zorimar Rivera-Núñez, Sinae Kim, et al.
Clinical Genitourinary Cancer|December 11, 2019
Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014Alexandra L Tabakin, Brian M Shinder, Sinae Kim, et al.
BMC Complementary Medicine and Therapies|July 4, 2025
Project HERO: a randomized trial of Tai Chi qigong versus intensity-matched exercise and usual care for fatigue in older male cancer survivorsAnita Y Kinney, Jinghua An, Yong Lin, et al.
Oncology Letters|January 4, 2020
A novel tumor suppressing gene, <i>ARHGAP9</i>, is an independent prognostic biomarker for bladder cancerXuan-Mei Piao, Pildu Jeong, Chunri Yan, et al.
Cancer Gene Therapy|June 22, 2019
Phase I neoadjuvant study of intravesical recombinant fowlpox-GM-CSF (rF-GM-CSF) or fowlpox-TRICOM (rF-TRICOM) in patients with bladder carcinomaDaniella E Portal, Robert E Weiss, Malgorzata Wojtowicz, et al.
Pageof 8